
The unexpectedly steep slowdown in economic growth in the first quarter of 2023 suggests the economy is feeling the brunt of persistently high inflation and rising interest rates. Also, the aftermath of the recent bank crisis and fears of a financial crunch are slowing the economy.
Amid an uncertain economic backdrop, investors should be wary and avoid fundamentally weak stocks Pliant Therapeutics, Inc. (PLRX), Local Bounti Corporation (LOCL), and Kiromic BioPharma, Inc. (KRBP) now. Let’s discuss this in detail.